The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

More than 20 Republican attorneys general are demanding that the Trump administration reinstate safety protocols for the ...

These High Resource Patients (HRP) are among the costliest to the healthcare system. According to a 2016 study by JMCP, five percent of the U.S. population accounts for 50 percent of all ...

Events that occurred in the ambulatory care setting were excluded. Preventable ADEs were categorized by drug or drug class, type of medication error, and the subsequent adverse outcome.

The FDA announced it has commenced daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS ...